The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
Francesco CaputoVincenzo DadduzioFrancesco TovoliGiulia BertoliniGiuseppe CabibboKrisida CermaCaterina VivaldiLuca FaloppiMario Domenico RizzatoFabio PiscagliaCiro CelsaLorenzo FornaroGiorgia MarisiFabio ContiNicola SilvestrisMarianna SillettaSara LonardiAlessandro GranitoCaterina StornelloValentina MassaGiorgio AstaraSabina DelcuratoloStefano CascinuMario ScartozziStefano CascinuPublished in: PloS one (2020)
PNI represents a prognostic tool in advanced HCC treated with first-line Sorafenib. It is readily available and low-cost, and it could be implemented in clinical practice in patients with HCC.
Keyphrases